PL2255791T3 - Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca bursztynian metoprololu - Google Patents

Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca bursztynian metoprololu

Info

Publication number
PL2255791T3
PL2255791T3 PL09159296T PL09159296T PL2255791T3 PL 2255791 T3 PL2255791 T3 PL 2255791T3 PL 09159296 T PL09159296 T PL 09159296T PL 09159296 T PL09159296 T PL 09159296T PL 2255791 T3 PL2255791 T3 PL 2255791T3
Authority
PL
Poland
Prior art keywords
extended release
pharmaceutical composition
metoprolol succinate
release pharmaceutical
pharmaceutically acceptable
Prior art date
Application number
PL09159296T
Other languages
English (en)
Inventor
Chitra Shah
Francisco Gual-Pujol
Joaquim Amela-Navarro
José Luis Ruiz-Córdoba
Original Assignee
Zakl Farmaceutyczne Polpharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zakl Farmaceutyczne Polpharma Sa filed Critical Zakl Farmaceutyczne Polpharma Sa
Publication of PL2255791T3 publication Critical patent/PL2255791T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
PL09159296T 2009-04-03 2009-05-04 Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca bursztynian metoprololu PL2255791T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09157343 2009-04-03
EP09159296A EP2255791B1 (en) 2009-04-03 2009-05-04 Extended release pharmaceutical composition comprising metoprolol succinate

Publications (1)

Publication Number Publication Date
PL2255791T3 true PL2255791T3 (pl) 2012-05-31

Family

ID=45217821

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09159296T PL2255791T3 (pl) 2009-04-03 2009-05-04 Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca bursztynian metoprololu

Country Status (5)

Country Link
US (1) US20100255105A1 (pl)
EP (1) EP2255791B1 (pl)
AT (1) ATE533475T1 (pl)
DK (1) DK2255791T3 (pl)
PL (1) PL2255791T3 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012052834A2 (en) * 2010-10-21 2012-04-26 Inventia Healthcare Private Limited Multiple unit particulate system comprising metoprolol succinate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE457505B (sv) 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
AU2003282375A1 (en) * 2003-02-05 2004-08-30 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
WO2007141593A2 (en) * 2005-12-23 2007-12-13 Medichem, S.A. Process for the preparation of metoprolol and its salts
MX2008010877A (es) * 2006-02-24 2008-11-25 Teva Pharma Tabletas de liberacion prolongada de succinato de metroprolol y metodos para su preparacion.
BRPI0714586A2 (pt) * 2006-07-28 2013-05-07 Farmaprojects S A formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço

Also Published As

Publication number Publication date
DK2255791T3 (da) 2012-03-05
US20100255105A1 (en) 2010-10-07
ATE533475T1 (de) 2011-12-15
EP2255791A1 (en) 2010-12-01
EP2255791B1 (en) 2011-11-16

Similar Documents

Publication Publication Date Title
IL214942A (en) N, n– Dimethyl-5– (2-methyl-6 - ((5-methylpyrazine-2-yl) carbamole) Benzoporen-4-Iloxy) Pyrimidine-2-carboxamide and the salts common in its pharmacies, pharmaceuticals containing them and their uses in the preparation of drugs
TN2009000093A1 (en) Pharmaceutical compositions comprising nilotinib or its salt
WO2010146179A3 (en) Solid pharmaceutical composition comprising rivaroxaban
PT1827396T (pt) Medicamento oral de libertação modificada de pelo menos um princípio ativo sob forma multimicrocapsular
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
IL201796A (en) Indole-3-Inglet or its pharmaceutical salts for use in the treatment of dermal lesion caused by papillomavirus
MX2010004323A (es) Formas de dosificacion oral que comprenden acetato de licarbazepina.
HK1164292A1 (en) Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
WO2012085927A3 (en) Tadalafil compositions
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
NZ598427A (en) Stabilized amorphous forms of imatinib mesylate with cyclodextrin complex
WO2009081174A3 (en) Anti - retroviral combination
IN2012DN03337A (pl)
WO2012087255A3 (en) Pharmaceutical formulations comprising imatinib
TN2012000038A1 (en) New compositions of 1-[-2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
IL201465A0 (en) Self-precipitating pharmaceutical formulations for the modified release of active principle
WO2008021410A3 (en) Highly pure pemetrexed diacid and processes for the preparation thereof
WO2010056039A3 (en) Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability
MY161749A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
WO2010115125A3 (en) Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2011064558A3 (en) Pharmaceutical composition
DE602008002371D1 (de) Pharmazeutische zusammensetzung mit candesartan-cilexetil
WO2010148314A3 (en) Preparation of esomeprazole and its pharmaceutically acceptable salts
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin